Characterizing Antibody Cross-reactivity for Immunoaffinity Purification of Analytes prior to Multiplexed Liquid Chromatography–Tandem Mass Spectrometry
Open Access
- 1 December 2012
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 58 (12) , 1711-1716
Abstract
BACKGROUND: Immunoassays for 1α,25-dihydroxyvitamin D [1α,25(OH)2D] lack analytical specificity. We characterized the cross-reactivity of an anti-1α,25(OH)2D antibody with purified vitamin D metabolites and used these data to map the chemical features of 1α,25(OH)2D that are important for antibody binding. Additionally, we hypothesized that when combined with isotope-dilution liquid chromatography–tandem mass spectrometry (LC-MS/MS), antibody cross-reactivity could be used to semiselectively enrich for structurally similar metabolites of vitamin D in a multiplexed assay. METHODS: Sample preparation consisted of immunoaffinity enrichment with a solid-phase anti-1α,25(OH)2D antibody and derivatization. Analytes were quantified with LC-MS/MS. Supplementation and recovery studies were performed for 11 vitamin D metabolites. We developed a method for simultaneously quantifying 25(OH)D2, 25(OH)D3, 24,25(OH)2D3, 1α,25(OH)2D2, and 1α,25(OH)2D3 that included deuterated internal standards for each analyte. RESULTS: The important chemical features of vitamin D metabolites for binding to the antibody were (a) native orientation of the hydroxyl group on carbon C3 in the A ring, (b) the lack of substitution at carbon C4 in the A ring, and (c) the overall polarity of the vitamin D metabolite. The multiplexed method had lower limits of quantification (20% CV) of 0.2 ng/mL, 1.0 ng/mL, 0.06 ng/mL, 3.4 pg/mL, and 2.8 pg/mL for 25(OH)D2, 25(OH)D3, 24,25(OH)2D3, 1α,25(OH)2D2, and 1α,25(OH)2D3, respectively. Method comparisons to 3 other LC-MS/MS methods yielded an r2 value >0.9, an intercept less than the lower limit of quantification, and a slope statistically indistinguishable from 1.0. CONCLUSIONS: LC-MS/MS can be used to characterize antibody cross-reactivity, a conclusion supported by our multiplexed assay for 5 vitamin D metabolites with immunoenrichment in a targeted metabolomic assay.Keywords
Funding Information
- National Institutes of Health (R01 GM63666, P30 DK035816)
- University of Washington
This publication has 21 references indexed in Scilit:
- An Inducible Cytochrome P450 3A4-Dependent Vitamin D Catabolic PathwayMolecular Pharmacology, 2012
- 3-epi-25 hydroxyvitamin D concentrations are not correlated with age in a cohort of infants and adultsClinica Chimica Acta, 2012
- Simultaneous measurement of plasma vitamin D3 metabolites, including 4β,25-dihydroxyvitamin D3, using liquid chromatography–tandem mass spectrometryAnalytical Biochemistry, 2011
- Quantification of 1α,25-Dihydroxy Vitamin D by Immunoextraction and Liquid Chromatography–Tandem Mass SpectrometryClinical Chemistry, 2011
- Sensitive measurement of serum 1α,25‐dihydroxyvitamin D by liquid chromatography/tandem mass spectrometry after removing interference with immunoaffinity extractionRapid Communications in Mass Spectrometry, 2011
- Quantitative determination of vitamin D metabolites in plasma using UHPLC-MS/MSAnalytical and Bioanalytical Chemistry, 2010
- A rubber transfer gasket to improve the throughput of liquid–liquid extraction in 96-well plates: Application to vitamin D testingJournal of Chromatography B, 2010
- Metabolic profiling of major vitamin D metabolites using Diels–Alder derivatization and ultra-performance liquid chromatography–tandem mass spectrometryAnalytical and Bioanalytical Chemistry, 2008
- Enzymes involved in the activation and inactivation of vitamin DTrends in Biochemical Sciences, 2004
- 25,26-Dihydroxycholecalciferol, a metabolite of vitamin D3 with intestinal calcium transport activityBiochemistry, 1970